Confidence In Blackline Grows As Total Addressable Market Seen Approaching $20 Billion
Cloud-based accounting software maker Blackline Inc (NASDAQ: BL) hosted a user conference this week, which has left sell-side analysts upbeat about the company's prospects.
The Analyst
KeyBanc Capital Markets analyst Brent Bracelin has an Overweight rating on shares, and raised his price target from $39 to $47.
Related Link: MuleSoft And BlackLine 2 SaaS Plays 'Making It Look Easy' Since Their IPOs
The Thesis
Following attendance of Blackline's user conference, spending two days with customers, partners and management, Braceline said three compelling growth drivers emerged, increasing his confidence in the sustainability of high growth through 2020.
The catalysts include:
Increasingly symbiotic relationship between the company and SAP SE (ADR) (NYSE: SAP), which fetches the company 19 percent of its total sales;
Expansion in the footprint at large enterprises, aided by Deloitte and KPMG; and
Broader opportunity to automate repetitive accounting functions, opening up a $18.5 billion untapped total addressable market, or TAM, opportunity.
"These new inputs give us an upward bias to the consensus estimate of 28.6% growth in 2018 and reinforce our view that BL should be a core holding for growth investors," Braceline said.
The Price Action
Blackline, which IPOed in late 2016, offering 8.6 million shares at $17 apiece, debuted on Wall Street with a gain of over 39 percent. The shares have done well since, climbing steadily and recording a gain of 36 percent in the year-to-date period.
Latest Ratings for BL
Nov 2017 | KeyBanc | Maintains | Overweight | |
Nov 2017 | JMP Securities | Upgrades | Market Perform | Market Outperform |
Jun 2017 | SunTrust Robinson Humphrey | Initiates Coverage On | Buy |
View More Analyst Ratings for BL
View the Latest Analyst Ratings
See more from Benzinga
Anadarko Petroleum's US Onshore Growth Isn't Priced Into The Stock Yet, Says BMO
Corium Q4 Sales Top Expectations Ahead Of Slew Of Near-Term Catalysts
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.